Tibet Rhodiola Pharmaceutical Holding (600211.SH) released the third quarter report for 2024, with the company's revenue for the first three quarters of the year reaching...
According to the Zhitong Finance APP, Tibet Rhodiola Pharmaceutical Holding (600211.SH) has released the third quarter report for 2024. The company's revenue for the first three quarters decreased by 8.13% to 2.175 billion yuan; the net income attributable to shareholders of the listed company decreased by 7.42% to 0.792 billion yuan; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses decreased by 6.22% to 0.687 billion yuan; and the basic earnings per share were 2.46 yuan per share.